Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
06/2014
06/17/2014CA2630273C Heterocyclylalkyl derivatives as inhibitors of histone deacetylase
06/17/2014CA2601979C 2,3 substituted pyrazine sulfonamides
06/17/2014CA2595848C Erastin and erastin binding proteins, and uses thereof
06/12/2014WO2014088085A1 Pyridone compound
06/12/2014WO2014087428A1 Process for preparation of vilazodone and intermediates thereof
06/12/2014WO2014086964A1 New derivatives of indole for the treatment of cancer, viral infections and lung diseases
06/12/2014WO2014086806A1 Pyridine-2-amides useful as cb2 agonists
06/12/2014WO2014086805A1 Pyridine-2-amides useful as cb2 agonists
06/12/2014WO2014086712A1 New indanyloxydihydrobenzofuranylacetic acids
06/12/2014WO2014086663A1 Substituted triazole and imidazole compounds
06/12/2014WO2014086284A1 Deuterated 3-cyano quinoline compound, pharmaceutical composition, preparation method and use thereof
06/12/2014WO2014086102A1 Indole full ketone derivative used as tyrosine-kinase inhibitor
06/12/2014WO2014062733A3 Substituted benzene compounds
06/12/2014US20140163227 Process for preparing vilazodone hydrochloride
06/12/2014US20140163082 Pyrazolyl compounds for use in reversing reactive gliosis
06/12/2014US20140163050 Use of 1H-quinazoline-2,4-diones
06/12/2014US20140163039 Piperazine-substituted benzothiophenes for treatment of mental disorders
06/12/2014US20140163032 Ethers, secondary amines and derivatives thereof as modulators of the 5-ht 2a serotonin receptor useful for the treatment of disorders related thereto
06/12/2014US20140163031 Substituted pyrazoles as n-type calcium channel blockers
06/12/2014US20140163025 Indanyloxydihydrobenzofuranylacetic acids
06/12/2014US20140162999 Pim kinase inhibitors and preparation methods and use in medicinal manufacture thereof
06/12/2014US20140162997 Substituted pyrazoles as n-type calcium channel blockers
06/12/2014US20140162983 Compositions and Methods for the Production of Pyrimidine and Pyridine Compounds with BTK Inhibitory Activity
06/12/2014US20140161801 Quinazoline derivative as tyrosine-kinase inhibitor, preparation method therefor and application thereof
06/12/2014US20140161729 Cofluorons and methods of making and using them
06/11/2014EP2740729A1 Quinazoline derivative, composition having the derivative, and use of the derivative in preparing medicament
06/11/2014EP2739619A1 Process for the preparation of olmesartan medoxomil
06/11/2014EP2739614A1 Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
06/11/2014CN103857680A Novel organic electroluminescent compounds and organic electroluminescent device using the same
06/11/2014CN103857670A 2-oxo-piperidinyl derivatives
06/11/2014CN103857661A 1,2,4-triazolyl-substituted keto-enols
06/11/2014CN103848834A Method for preparing ticagrelor and intermediate of ticagrelor
06/11/2014CN103848824A Coumarin-triazole compound as well as preparation method and application thereof
06/11/2014CN103848823A Compound for treating neurodegenerative diseases and application thereof
06/11/2014CN103848821A Spiro compound serving as hepatitis C inhibitor, drug composition and applications of spiro compound and drug composition
06/11/2014CN103848820A Spiro compound serving as hepatitis C inhibitor and applications thereof in drugs
06/11/2014CN103848819A Spiro compound serving as hepatitis C inhibitor, drug composition and applications of spiro compound and drug composition in drugs
06/11/2014CN103848814A Substituted indole ketone derivative as tyrosine kinase inhibitor
06/11/2014CN103848792A 4,4-disubstituted-dihydro-2-(1H)-quinazolinone as well as synthetic method and use thereof
06/11/2014CN103848785A Perylene 3-cyano quinoline compound, medicinal compound, and preparation method and use thereof
06/11/2014CN103848771A C-3 substituted chiral succinimide and preparation method thereof
06/11/2014CN103848767A Synthetic method of aryl thioether compound
06/11/2014CN103130766B Piperine hydrazone or acylhydrazone or sulfonyl hydrazone derivative substances and application for preparing a botanical insecticide
06/11/2014CN102596936B Antiviral compounds
06/10/2014US8748613 Quinuclidine esters of 1-azaheterocyclylacetic acid as antimuscarinic agents, process for their preparation and medicinal compositions thereof
06/10/2014US8748597 2,4-pyrimidinediamine compounds and their uses
06/10/2014US8748476 Darifenacin for use in the treatment of urgency induced by overactive bladder
06/10/2014US8748459 Pyridinoylpiperidines as 5-HT1F agonists
06/10/2014US8748442 sGC stimulators
06/10/2014CA2541509C Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases
06/05/2014WO2014085607A1 Substituted 2,3-dihydrobenzofuranyl compounds and uses thereof
06/05/2014WO2014085545A1 Methods and compositions involving rad51 inhibitors
06/05/2014WO2014084407A1 Dihydropyrone compounds and herbicides comprising the same
06/05/2014WO2014084330A1 Nitrogen-containing heterocyclic compound
06/05/2014WO2014084223A1 Tetrazolinone compound and use thereof
06/05/2014WO2014084170A1 Transparent electrode, electronic device, and organic electroluminescence element
06/05/2014WO2014082918A1 New indanyloxydihydrobenzofuranylacetic acids
06/05/2014WO2014082381A1 Spiro ring compounds as hepatitis c virus inhibitors, pharmaceutical compositions and uses thereof
06/05/2014WO2014082379A1 Spiro ring compound as hepatitis c virus (hcv) inhibitor and uses thereof field of the invention
06/05/2014US20140155615 Compound containing pyridine ring and method for producing halogenated picoline derivative and tetrazolyloxime derivative
06/05/2014US20140155613 Compound containing pyridine ring and method for producing halogenated picoline derivative and tetrazolyloxime derivative
06/05/2014US20140155596 Cysteinyl leukotriene antagonists
06/05/2014US20140155421 Substituted pyrimidinyl-pyrroles active as kinase inhibitors
06/05/2014US20140155418 Receptor-Type Kinase Modulators and Methods of Use
06/05/2014US20140155415 Benzodioxepine and benzodioxine compounds that interact with glucokinase regulatory protein for the treatment of diabetes
06/05/2014US20140155413 TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF
06/05/2014US20140155408 Pyruvate kinase activators for use in therapy
06/05/2014US20140155407 Selective cyp11b1 inhibitors for the treatment of cortisol dependent diseases
06/05/2014US20140155403 Cyclic triazo and diazo sodium channel blockers
06/05/2014US20140155402 Bi-heteroaryl compounds as vps34 inhibitors
06/05/2014US20140155378 c-Met Modulators and Method of Use
06/05/2014US20140155370 Nuclear transport modulators and uses thereof
06/05/2014US20140154319 Pharmaceutical composition for the treatment and prevention of cardiac disease
06/04/2014EP2738166A1 Nitrogenated aromatic heterocyclic derivative, and organic electroluminescent element using same
06/04/2014EP2736897A1 Substituted picolinic acids and pyrimidine-4-carboxylic acids, method for the production thereof, and use thereof as herbicides and plant growth regulators
06/04/2014EP2736896A1 3-oxo-2,3-dihydro-1h-indazole-4-carboxamide derivatives as parp-1 inhibitors
06/04/2014EP2736514A1 Alkynyl substituted pyrimidinyl-pyrroles active as kinases inhibitors
06/04/2014EP2736493A1 Antioxidant, neuroprotective and antineoplastic nanoparticles comprising a therapeutic agent on an amphiphilic spacer or an amphiphilic polymer
06/04/2014CN1585772B Chemokine receptor antagonists and methods of use thereof
06/04/2014CN103842364A Anti-viral compounds
06/04/2014CN103842356A 1 - arylcarbonyl - 4 - oxy - piperidine compounds useful for the treatment of neurodegenerative diseases
06/04/2014CN103842347A Amide compound and use thereof for controlling harmful arthropods
06/04/2014CN103842339A Carbazole derivatives for organic electroluminescence devices
06/04/2014CN103841961A Antioxidant, neuroprotective and antineoplastic nanoparticles comprising a therapeutic agent on an amphiphilic spacer or an amphiphilic polymer
06/04/2014CN103833739A A calcium-zinc composite heat stabilizer, a preparation method thereof and applications thereof
06/04/2014CN103833738A Blue phosphorescence compound and organic light emitting diode using the same
06/04/2014CN103833737A Method for preparing an intermediate of pitavastatin or of the salt thereof
06/04/2014CN103833730A Benzo five-membered nitrogen-containing heterocycle-based piperazine derivative and preparation method as well as application thereof
06/04/2014CN103833658A Benzotriazole-based piperazine compound as well as preparation method and pharmaceutical composition thereof
06/04/2014CN103833643A Benzimidazolyl-piperazine compound and preparation method and pharmaceutical composition thereof
06/04/2014CN103833642A Application of benzo five-membered nitrogen-containing heterocycle-based piperazine derivative
06/04/2014CN103833507A Organic electroluminescent materials, and preparation method and application thereof
06/04/2014CN102807551B Liquid crystal compound containing dioxa saturated azulenes and composition thereof
06/04/2014CN102712624B Indole compound and pharmaceutical use thereof
06/04/2014CN102516229B Fluorescent probe for detecting histidine, precursor thereof and preparation methods of fluorescent probe and precursor
06/04/2014CN102264704B Isoquinoline derivative
06/04/2014CN101862345B Modified nucleosides for treatment of viral infections and abnormal cellular proliferation
06/03/2014US8742132 Indolylmaleimide derivatives processes for their production and pharmaceutical compositions
06/03/2014US8742122 Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
06/03/2014US8742097 Triazole compounds I
1 ... 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 ... 694